Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Lilly to Acquire Centessa for Sleep-Wake Disorders
Announced
HealthcareMerger
Deal Overview
Lilly agreed to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders. The deal is described as a merger.
The excerpt provided does not include consideration, valuation, or timing details, but the stated strategic focus is developing therapies for sleep-wake disorder indications.
Key Details
- Transaction
- Lilly acquires Centessa Pharmaceuticals
- Deal Size
- Over $100M
Related Deals
Marksans Pharma Acquires Netherlands-Based QliniQ B.V. for €7.5m to Expand EU Reach - scanx.trade
HealthcareAdd-on
Marksans Pharma→QliniQ
Jun 1, 2026
Altruix Acquired By Frazier Healthcare Partners And Randy Hyun Appointed CEO - Pulse 2.0
HealthcareOther
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos Secures $20M to Expand CGM Use Beyond Diabetes Into Weight Loss
HealthcareOther
Signos
May 31, 2026
Sterling Bay Partnership Secures $290M Financing for Sorrento Mesa’s Pacific Center
HealthcareCaliforniaOther
Sterling Bay→Pacific Center
May 29, 2026